BTCY | Biotricity, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.3252 - 0.3252
52 Week Range	0.3252 - 2.4300
Beta	1.78
Implied Volatility	504.73%
IV Rank	79.22%
Day's Volume	150
Average Volume	76,376
Shares Outstanding	22,454,600
Market Cap	7,301,113
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2018-02-16

Valuation
Profitability
Growth
Health
P/E Ratio	-0.19
Forward P/E Ratio	N/A
EPS	-1.74
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	55
Country	USA
Website	BTCY

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

BTCY's peers: CVRX, BBLG, DCTH, HSCS, MODD, NSYS, PETV, BSGM, SRDX, BMRA, MOVE, AIMD, INVO, NMRD, BJDX, NVNO, PAVM, NARI, TELA, MXCT, CLPT, NMTC

*Chart delayed

Analyzing fundamentals for BTCY we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see BTCY Fundamentals page.

Watching at BTCY technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on BTCY Technicals page.